[DISCLOSURE] Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns.
By Park Yuna ()
Published : Sept. 5, 2016 - 10:35:39
[DISCLOSURE] Cell Biotech (049960) said on Sept. 5 that it has acquired a patent for a composition that prevents and treats inflammatory bowel disease, based on four kinds of probiotics lactic acid bacteria that the company owns.
By Park Yuna ()